|
|
|
|
|
|
Business Development |
|
 |
|
Business Development
Business development is at the core of our business philosophy. The development of products and services with the end user and particularly the Orphan Drug Market in mind is where we excel. Our expertise in developing product proliferation opportunities, new drugs within the orphan category or synthesis of radiopharmaceuticals from existing marketed pharmaceuticals is a core competency of Brogan Pharmaceuticals. Of particular interest to our clients are our intellectual property capabilities, Orphan Sponsorship for foreign entities, Orphan Designation Development and the Licensing of new products or services. Please contact us with a specific inquiry. |
More to See:
Value, experience, execution! We will work with you in a collaborative manner to overcome the operational costs, distribution nexus, and current paradigm in the industry. The current paradigm commonly associated with the synthesis, manufacture, and distribution of radiopharmaceuticals in the United States is ineffective further driving up cost and obstructing research and development. We will cut cycle times and effectively work to achieve the return on investment your product deserves.
|
|
Brogan Pharmaceuticals, Inc. © 2007 | Home | FAQs | Contact | Site Map |
|
